Collegium Pharmaceutical Inc (COLL)
30.40
+0.40
(+1.33%)
USD |
NASDAQ |
Nov 21, 16:00
30.40
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Gross Profit Margin (Quarterly): 60.76% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 60.76% |
| June 30, 2024 | 62.51% |
| March 31, 2024 | 63.11% |
| December 31, 2023 | 63.19% |
| September 30, 2023 | 58.75% |
| June 30, 2023 | 54.47% |
| March 31, 2023 | 53.47% |
| December 31, 2022 | 38.41% |
| September 30, 2022 | 46.33% |
| June 30, 2022 | 42.38% |
| March 31, 2022 | 57.90% |
| December 31, 2021 | -4.87% |
| September 30, 2021 | 58.49% |
| June 30, 2021 | 60.57% |
| March 31, 2021 | 63.38% |
| December 31, 2020 | 58.07% |
| September 30, 2020 | 60.87% |
| Date | Value |
|---|---|
| June 30, 2020 | 61.96% |
| March 31, 2020 | 50.96% |
| December 31, 2019 | 33.85% |
| September 30, 2019 | 35.90% |
| June 30, 2019 | 35.16% |
| March 31, 2019 | 34.02% |
| December 31, 2018 | 59.52% |
| September 30, 2018 | 34.44% |
| June 30, 2018 | 35.89% |
| March 31, 2018 | 32.38% |
| December 31, 2017 | 89.86% |
| September 30, 2017 | 95.37% |
| June 30, 2017 | 83.79% |
| March 31, 2017 | 82.92% |
| December 31, 2016 | 85.88% |
| September 30, 2016 | 92.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-4.87%
Minimum
Dec 2021
63.38%
Maximum
Mar 2021
52.23%
Average
58.28%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| Context Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 42.30% |
| Return on Assets | 7.23% |
| Return on Invested Capital | 9.91% |
| Profit Margin (Quarterly) | 5.86% |
| Operating Margin (Quarterly) | 21.87% |
| Return on Net Operating Assets | 9.79% |